Data as of 3:58pm ET
| -0.47 / -0.65%|
The 4 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 85.50, with a high estimate of 92.00 and a low estimate of 75.00. The median estimate represents a +19.70% increase from the last price of 71.43.
The current consensus among 4 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.